GSK to invest in venture fund for orphan drug discovery

06/20/2013 | Reuters

GlaxoSmithKline is investing $23.5 million in Kurma Biofund II, a venture capital fund that works with a network of research institutes in Europe and focuses on rare diseases. GSK invested earlier this year in Avalon Ventures to fund up to 10 drug discovery startup companies over the next three years.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA